Llwytho...
Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study
BACKGROUND: Accumulation of epicardial fat (EF) is associated with increased cardio-metabolic risks and coronary events, independently of traditional cardiovascular risk factors. Therefore, the reduction of EF volume (EFV) may be associated with reduced cardio-metabolic risks and future cardiovascul...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cardiovasc Diabetol |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5335851/ https://ncbi.nlm.nih.gov/pubmed/28253918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-017-0516-8 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|